Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jul. 31, 2022
Accounting Policies [Abstract]  
Schedule of the Effect of Corrections A summary of the effect of the corrections on the condensed consolidated statements of operations for the three and six months ended July 31, 2021 were as follows (in thousands, except per share data):
Three Months Ended July 31, 2021
Six Months Ended July 31, 2021
As reported Corrections As Adjusted As reported Corrections As Adjusted
Operating expenses:
Research and development $ 15,087  $ (49) $ 15,038  $ 28,215  $ (89) $ 28,126 
Sales and marketing 70,249  (847) 69,402  130,887  (1,013) 129,874 
Total operating expenses 110,659  (896) 109,763  200,633  (1,102) 199,531 
Operating loss (29,305) 896  (28,409) (40,008) 1,102  (38,906)
Loss before provision for income taxes (30,741) 896  (29,845) (43,635) 1,102  (42,533)
Net loss (33,247) 896  (32,351) (47,944) 1,102  (46,842)
Net loss per share attributable to Class A and Class B stockholders, basic and diluted $ (0.20) $ —  $ (0.19) $ (0.36) $ —  $ (0.35)
A summary of the effect of the corrections on the condensed consolidated statements of cash flows for the six months ended July 31, 2021 were as follows (in thousands):
Six Months Ended July 31, 2021
As reported Corrections As Adjusted
Net loss (47,944) 1,102  (46,842)
Changes in operating assets and liabilities
Prepaid expenses and other current assets 1,673  (585) 1,088 
Other non-current assets (7,151) (517) (7,668)